M&A - TRANSAMERICA FUNDS

Form Type: 497

Filing Date: 2025-03-07

Corporate Action: Merger

Type: Update

Accession Number: 000119312525049474

Filing Summary: The document announces the approval by the Board of Trustees for a series of reorganizations involving Transamerica Funds. Specifically, the assets of various Target Funds, including Transamerica ClearTrack® 2025, 2030, 2035, 2040, 2045, and 2050, will be reorganized into corresponding Destination Funds. Shareholders of each Target Fund will receive Class R3 shares of their respective Destination Funds, maintaining the same aggregate net asset value. These transactions are not expected to trigger any gain or loss for the shareholders for Federal income tax purposes. The reorganizations, which do not require shareholder approval, are expected to take place around June 20, 2025, pending the satisfaction of certain closing conditions. Prior to the effective closure date of June 18, 2025, shareholders will still be able to engage in purchases, redemptions, and exchanges of each Target Fund’s shares.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-07

Corporate Action: Merger

Type: New

Accession Number: 000119312525049478

Filing Summary: The Board of Trustees has approved reorganizations involving the Transamerica ClearTrack® funds, where the assets of each Target Fund—including Transamerica ClearTrack® 2025, 2030, 2035, 2040, 2045, 2050, and Retirement Income—will be merged into corresponding Destination Funds. Shareholders of each Target Fund will receive Class R3 shares of the Destination Fund equivalent in aggregate net asset value to their existing shares. No gain or loss for Federal income tax purposes will be recognized by shareholders. Although these reorganizations do not require shareholder approval, they are contingent on certain closing conditions. The expected effective date for these changes is June 20, 2025, after which the Target Funds will close to new investments on June 18, 2025. Investors are advised to keep this supplement for future reference.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-07

Corporate Action: Merger

Type: New

Accession Number: 000119312525049480

Filing Summary: The Board of Trustees approved reorganizations involving several Target Funds within the Transamerica Funds. The assets of the Target Funds will be reorganized into corresponding Destination Funds. Each Target Fund's shareholders will receive Class R3 shares of the applicable Destination Fund, maintaining the same aggregate net asset value as their existing shares. This reorganization is expected to not result in any gain or loss for Federal income tax purposes for shareholders. An information statement will be sent to shareholders before the reorganizations, which do not require shareholder approval but are subject to certain closing conditions. The reorganizations are expected to take place around June 20, 2025, with investments in the Target Funds closing on June 18, 2025. Prior to this date, shareholders may continue to transact with their shares as per the terms outlined in each fund's Prospectus and Summary Prospectus.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-07

Corporate Action: Merger

Type: Update

Accession Number: 000119312525049481

Filing Summary: The Board of Trustees of Transamerica Funds has approved the reorganization of several Target Funds into their corresponding Destination Funds. This will involve the transfer of assets from each Target Fund to a designated Destination Fund, with shareholders receiving Class R3 shares in the Destination Funds equivalent to the net asset value of their Class R3 shares in the Target Funds. Tax implications indicate no gain or loss for shareholders is expected to occur due to these reorganizations. Shareholder approval is not needed, but the reorganizations depend on the satisfaction of specific closing conditions, with a projected completion date around June 20, 2025. Prior to this date, shareholders can buy, redeem, and exchange shares of the Target Funds. The affected Target Funds include Transamerica ClearTrack® 2025, 2030, 2035, 2040, 2045, and associated other funds.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-07

Corporate Action: Merger

Type: Update

Accession Number: 000119312525049482

Filing Summary: The Board of Trustees has approved reorganizations of several Target Funds within Transamerica Funds. This includes the Transamerica ClearTrack® series. Each Target Fund's assets will be reorganized into corresponding Destination Funds, with Target Fund shareholders receiving Class R3 shares of the Destination Funds. No federal income tax gain or loss is anticipated for shareholders as a result of these reorganizations. An information statement will be sent to Target Fund shareholders ahead of the closing. The reorganizations do not require shareholder approval but are dependent on certain conditions being met. The reorganizations are expected to occur on or about June 20, 2025, with Target Funds closing to new investments effective as of June 18, 2025. Shareholders may still transact in Target Funds prior to this date as per each fund's guidelines.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-07

Corporate Action: Merger

Type: New

Accession Number: 000119312525049483

Filing Summary: The Board of Trustees has approved reorganizations for several Transamerica Funds. The assets of each Target Fund will be reorganized with and into a corresponding Destination Fund. Shareholders of the Target Funds will receive Class R3 shares of the Destination Funds, maintaining the same aggregate net asset value. The reorganizations aim to be tax-neutral for shareholders, with no gain or loss recognized for Federal income tax purposes. An information statement will be sent to shareholders prior to the reorganizations, which do not require shareholder approval but must meet certain closing conditions. If conditions are met, reorganizations are expected to occur on or about June 20, 2025, and the Target Funds will close to new investments on or about June 18, 2025.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-07

Corporate Action: Merger

Type: Update

Accession Number: 000119312525049484

Filing Summary: The Board of Trustees of Transamerica Funds has approved a series of reorganizations affecting several Target Funds, specifically, the Transamerica ClearTrack® series funds, which include Transamerica ClearTrack® 2025, 2030, 2035, 2040, 2045, and 2050, along with the Transamerica ClearTrack® Retirement Income fund. Under these reorganizations, the assets of each Target Fund will be reorganized into its corresponding Destination Fund. Shareholders of each Target Fund are set to receive Class R3 shares in the Destination Fund equivalent in aggregate net asset value to their shares in the Target Fund. It is projected that this reorganization will not yield any taxable gains or losses for the shareholders under Federal income tax laws. An information statement detailing the reorganizations will be sent to shareholders prior to the closing, which is scheduled to occur on or about June 20, 2025. Although shareholder approval is not necessary for these reorganizations, they depend on meeting certain closing conditions. Furthermore, as of the close of business on or about June 18, 2025, each Target Fund will cease to accept new investments, although current shareholders will retain the ability to purchase, redeem, and exchange shares until that date.

Document Link: View Document